Anavex Life Sciences Corp. (AVXL)
4.26
+0.16
(+3.90%)
USD |
NASDAQ |
Jan 08, 16:00
4.35
+0.09
(+2.11%)
After-Hours: 19:51
Anavex Life Sciences Research and Development Expense (Annual): 37.59M for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 74.43M |
| CorMedix, Inc. | 3.942M |
| Verastem, Inc. | 81.33M |
| ADMA Biologics, Inc. | 1.813M |
| Aldeyra Therapeutics, Inc. | 48.22M |